Fiber Choice Weight Management Interactions
There are 82 drugs known to interact with Fiber Choice Weight Management (chromium picolinate / inulin), along with 4 disease interactions. Of the total drug interactions, 1 is major, 80 are moderate, and 1 is minor.
- View all 82 medications that may interact with Fiber Choice Weight Management
- View Fiber Choice Weight Management disease interactions (4)
Most frequently checked interactions
View interaction reports for Fiber Choice Weight Management (chromium picolinate / inulin) and the medicines listed below.
- albuterol
- Aspirin Low Strength (aspirin)
- biotin
- bupropion
- Calcium 600 D (calcium / vitamin d)
- CoQ10 (ubiquinone)
- Cymbalta (duloxetine)
- estradiol
- Fish Oil (omega-3 polyunsaturated fatty acids)
- gabapentin
- hydrochlorothiazide
- Iron Sulfate (ferrous sulfate)
- levothyroxine
- Lexapro (escitalopram)
- lisinopril
- loratadine
- magnesium oxide
- melatonin
- metformin
- MiraLAX (polyethylene glycol 3350)
- multivitamin
- omeprazole
- potassium chloride
- Prilosec (omeprazole)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- simvastatin
- turmeric
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Fiber Choice Weight Management disease interactions
There are 4 disease interactions with Fiber Choice Weight Management (chromium picolinate / inulin) which include:
- inflammatory bowel disease
- intestinal obstruction disorders
- renal dysfunction
- malabsorption syndromes
Report options
QR code containing a link to this page
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.